Results 81 to 90 of about 21,989 (186)

Utility of the interferon-gamma release assay for latent tuberculosis infection screening among indian health-care workers

open access: yesIndian Journal of Community Medicine, 2021
Background: The utility of interferon-gamma release assays (IGRAs) for latent tuberculosis infection (LTBI) screening among health-care workers (HCWs) in low- and middle-income countries (LMICs) remains unclear.
Sunita Girish   +14 more
doaj   +1 more source

Aqueous extract‐mediated green synthesis of CuO nanoparticles: Potential anti‐tuberculosis agents

open access: yesFood Science &Nutrition, Volume 12, Issue 8, Page 5907-5921, August 2024.
In sum, the mixture of garlic extract and nanoparticles at 100 mg/kg body weight of rats inhibited tuberculosis infection. It exhibited antibacterial activity and antioxidant properties in lung tissue and prevented lung damage. The results are promising and show that garlic extract and nanoparticles can be utilized to prevent tuberculosis.
Zohreh Zamanian   +3 more
wiley   +1 more source

Factors influencing the sensitivity of QFT-GIT according to age group. [PDF]

open access: yes, 2016
Factors influencing the sensitivity of QFT-GIT according to age group.
Jong Sun Park (2816584)   +10 more
core   +1 more source

QFT-Plus positivity risk factor analysis-Zambia. [PDF]

open access: yes, 2023
BackgroundFrom 2018–2021 the TB Reduction through Expanded Antiretroviral Treatment and TB Screening (TREATS) project took place in 21 Zambian and South African communities.
Robynn Paulsen (16548398)   +14 more
core   +1 more source

Revisiting Bacille Calmette‐Guérin revaccination strategies: timing of immunization, Mycobacterium tuberculosis and non‐tuberculous mycobacteria infections, strain potency and standardization of randomized controlled trials

open access: yesClinical and Translational Discovery, Volume 4, Issue 3, June 2024.
1) Bacille Calmette‐Guérin (BCG) revaccination timing is crucial for enhancing immunity, particularly in adolescents and young adults. 2) Prior Mycobacterium tuberculosis or non‐tuberculous mycobacteria infections may influence the perceived efficacy of BCG revaccination.
Wenping Gong   +4 more
wiley   +1 more source

Factors associated with concordance and discordance between QFT-GIT and TST. [PDF]

open access: yes, 2018
Factors associated with concordance and discordance between QFT-GIT and TST.
Nikhil Gupte (189999)   +20 more
core   +1 more source

Interferon-γ release assays for the diagnosis of tuberculosis and tuberculosis infection in HIV-infected adults: a systematic review and meta-analysis.

open access: yesPLoS ONE, 2012
BackgroundDespite the widespread use of interferon-γ release assays (IGRAs), their role in diagnosing tuberculosis and targeting preventive therapy in HIV-infected patients remains unclear.
Miguel Santin, Laura Muñoz, David Rigau
doaj   +1 more source

Prevalence of latent tuberculosis infection in Asian nations: A systematic review and meta‐analysis

open access: yesImmunity, Inflammation and Disease, Volume 12, Issue 2, February 2024.
Abstract Background Tuberculosis (TB) is a serious public health concern around the world including Asia. TB burden is high in Asian countries and significant population harbor latent tuberculosis infection(LTBI). Aim This systematic review and meta‐analysis aims to evaluate the prevalence of LTBI in Asian countries.
Abhigan B. Shrestha   +14 more
wiley   +1 more source

QuantiFERON-TB Gold In-Tube test (QFT-GIT) for the screening of latent tuberculosis in recent immigrants to Italy [PDF]

open access: yes, 2009
To evaluate the agreement between QuantiFERON-TB Gold In-Tube test (QFT-GIT) and tuberculin skin test (TST) for the screening of latent tuberculosis infection (LTBI) in recent immigrants to Italy, 279 subjects were submitted to concomitant TST and QFT ...
DI TULLIO R   +11 more
core  

Results of the T-SPOT.TB for adults with indeterminate QFT-GIT results. [PDF]

open access: yes, 2015
Results of the T-SPOT.TB for adults with indeterminate QFT-GIT results.
Ni Diao (207358)   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy